Device entrapment during percutaneous coronary intervention
- PMID: 35312151
- PMCID: PMC9544850
- DOI: 10.1002/ccd.30160
Device entrapment during percutaneous coronary intervention
Abstract
Introduction: Device entrapment is a life-threatening complication during percutaneous coronary intervention (PCI). However, the success for its management is predominantly based on operator experience with limited available guidance in the published literature.
Methods: A systematic review was performed on December 2021; we searched PubMed for articles on device entrapment during PCI. In addition, backward snowballing (i.e., review of references from identified articles and pertinent reviews) was employed.
Results: A total of 4209 articles were retrieved, of which 150 studies were included in the synthesis of the data. A methodical algorithmic approach to prevention and management of device entrapment can help to optimize outcomes. The recommended sequence of steps are as follows: (a) pulling, (b) trapping, (c) snaring, (d) plaque modification, (e) telescoping, and (f) surgery.
Conclusions: In-depth knowledge of the techniques and necessary tools can help optimize the likelihood of successful equipment retrieval and minimization of complications.
Keywords: PCI; complications; coronary artery disease; percutaneous coronary intervention.
© 2022 The Authors. Catheterization and Cardiovascular Interventions published by Wiley Periodicals LLC.
Conflict of interest statement
Kambis Mashayekhi reports consulting/speaker/proctoring honoraria from Abbott Vascular, Abiomed, Ashai Intecc, AstraZeneca, Biotronik, Boston Scientific, Cardinal Health, Daiichi Sankyo, Medtronic, Shockwave Medical, Teleflex, and Terumo. Emmanouil S. Brilakis reports consulting/speaker honoraria from Abbott Vascular, American Heart Association (associate editor Circulation), Amgen, Asahi Intecc, Biotronik, Boston Scientific, Cardiovascular Innovations Foundation (Board of Directors), ControlRad, CSI, Elsevier, GE Healthcare, IMDS, InfraRedx, Medicure, Medtronic, Opsens, Siemens, and Teleflex; owner, and Hippocrates LLC; shareholder: MHI Ventures and Cleerly Health. Pierfrancesco Agostoni reports consulting/speaker/proctoring honoraria from Abbott Vascular, Boston Scientific, Medtronic, and Neovasc. Gabriele L. Gasparini reports consulting/speaker/proctoring honoraria from Terumo, Asahi Intecc, IMDS, Boston Scientific, Medtronic, Abbott Vascular, and Cardinal Health. Mohaned Egred reports consulting/speaker/proctoring honoraria from Abbott Vascular, Boston Scientific, Philips, Spectranetics, Volcano, Teleflex, Vascular Perspective, Merrill, Sveltte, EPS Medical, and AstraZeneca. Alexandre Avran reports consulting/speaker/proctoring honoraria from Boston, Biotronik, Terumo, Asahi, Orbus, Abbott, IMDS, and Alvimedica. Roberto Garbo reports consulting/speaker/proctoring honoraria from Teleflex, Abbott Vascular, IMDS, Terumo, Asahi Intecc, and Boston Scientific. Arun Kalyanasundaram and Jorge Sanz‐Sánchez report no conflicts of interest.
Figures
References
-
- Patel VG, Brayton KM, Tamayo A, et al. Angiographic success and procedural complications in patients undergoing percutaneous coronary chronic total occlusion interventions: a weighted meta‐analysis of 18,061 patients from 65 studies. JACC Cardiovasc Interv. 2013;6:128‐136. - PubMed
-
- Danek BA, Karatasakis A, Brilakis ES. Consequences and treatment of guidewire entrapment and fracture during percutaneous coronary intervention. Cardiovasc Revasc Med. 2016;17:129‐133. - PubMed
-
- Brilakis E. Manual of percutaneous coronary interventions: a step‐by‐step approach. Elsevier; 2021.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous
